Remove pharmaceutical-engineering January-February-2023
article thumbnail

Innovations: The Future of Pharmaceutical Facilities

ISPE

The two-day conference on 31 January–1 February featured a range of sessions on topics including biomanufacturing, cell and gene therapy, digital transformation and Pharma 4.0™, Hartman noted the importance of attendees’ work in bringing pharmaceuticals to patients. ™, emerging technologies, and facility design and construction.

article thumbnail

2022 Roger F. Sherwood Article of the Year Award Finalists Announced

ISPE

Sherwood Article of the Year Award Finalists Announced Trudy Patterson Thu, 08/17/2023 - 11:22 iSpeak Blog iSpeak 2022 Roger F. Sherwood Article of the Year Award Finalists Announced ISPE 17 August 2023 Pharmaceutical Engineering ® is delighted to announce the finalists for the 2022 Roger F. 2022 Roger F.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Life-Cycle Approach to Cleaning Topical Drug Products

ISPE

Life-Cycle Approach to Cleaning Topical Drug Products Trudy Patterson Wed, 01/11/2023 - 10:17 Technical January / February 2023 Life-Cycle Approach to Cleaning Topical Drug Products Dijana Hadziselimovic Kamini I. January 2012. January 2011. Cleaning Engineering and Equipment Design.” August 2014.

article thumbnail

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma

ISPE

ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma Trudy Patterson Mon, 07/10/2023 - 15:37 Technical July / August 2023 ChatGPT, BARD, and Other Large Language Models Meet Regulated Pharma Martin Heitmann, FRM Stefan MÜNCH Brandi M. Specific aspects of pharmaceutical roles (e.g.,

article thumbnail

Next Generation RNA Therapeutics and Vaccines – A Marvel of The Lifesciences Industry

Roots Analysis

The support from venture capitalists and big pharmaceutical companies will continue to drive the development of circular RNA therapeutics and RNA therapeutics market growth over the forecast period. Considering the potential of these therapies, several industry stakeholders are actively engaging in the development of such therapeutics.

article thumbnail

Advancing AOCs to transform the delivery of RNA therapeutics

European Pharmaceutical Review

Based on learnings from ASOs and siRNAs they also leverage unique engineering and drug delivery techniques that enable them to target a broader set of cell types, including many that have been previously untreatable with RNA therapeutics. Sunesis Pharmaceuticals (merged with Viracta Therapeutics in February 2021) and Gilead Sciences.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. McQueen Nina S.